Interferon alpha (IFN) treatment of bone marrow stroma inhibits haematopoesis

Leuk Res. 2004 Nov;28(11):1217-20. doi: 10.1016/j.leukres.2004.03.012.

Abstract

Prolonged pre-transplant IFN administration in patients with chronic myeloid leukaemia has been associated with an increased risk of fatal transplant-related complications and an inferior outcome after allogeneic bone marrow transplantation. Using a two-stage long-term bone marrow culture as an in vitro model we were able to show a negative effect of higher doses of IFN pre-treatment of bone marrow stroma on haematopoesis. This correlated with a decline in the number of monocytes-macrophages. While monocytes-macrophages itself produce cytokines, a vicious circle may lead to an ineffective function of the microenvironment resulting in ineffective haematopoieses and increased transplant-related complications.

MeSH terms

  • Bone Marrow / drug effects*
  • Hematopoiesis / drug effects*
  • Humans
  • Interferon-alpha / pharmacology*
  • Stromal Cells / drug effects*

Substances

  • Interferon-alpha